KaloBios Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile by GlobalData

VIEWS: 0 PAGES: 27

More Info
									         KaloBios Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and
                                     Alliances Profile
       Reference Code: GDPH140541D                                                                                                             Publication Date: APR 2013

      Company Overview                                                                                        Key Facts
      KaloBios Pharmaceuticals, Inc. (KaloBios) is a pharmaceutical company, based in
                                                                                                              KaloBios Pharmaceuticals, Inc., Pharmaceuticals &
      the US. The company develops new human antibody therapeutics based on its
                                                                                                              Healthcare, Key Facts
      proprietary antibody engineering technology. Its product pipeline includes KB001A,
      KB003 and KB004. KB001A, is a Humaneered, high-affinity antibody fragment used                           Web Address                           www.kalobios.com
      for the treatment of pseudomonas aeruginosa (Pa) infections. KB003 is a potent
                                                                                                               Revenue (US$ million)                                NA
      inhibitor of GM-CSF developed for inflammatory and autoimmune indications.
      KB004 targets hematologic malignancies, solid tumors, and their stem cells.                              Number of Employees                                  NA
                                                                                                               GlobalData

      Financial Deals Landscape
        KaloBios Pharmaceuticals, Inc., Pharmaceuticals & Healthcare,                     KaloBios Pharmaceuticals, Inc., Pharmaceuticals &
        Deals by Type, 2007 to YTD 2013                                                   Healthcare, Deals By Year, 2007 to YTD 2013


                                                                                                                 2         2
                                                                                                          2


                                                                                           No. of Deals                                    1         1    1          1
                                                                                                          1


                                                                                                                                  0
                                                                                                          0
                                                                                                               2007       2008   2009     2010   2011    2012       YTD
                                                                                                                                                                    2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         KaloBios Pharmaceuticals, Inc., Pharmaceuticals &                                KaloBios Pharmaceuticals, Inc., Pharmaceuticals &
         Healthcare, Deals By Region, 2007 to YTD 2013                                    Healthcare, Deals By Therapy Area, 2007 to YTD 2013

                         10     8                                                                         6
                                                                                                                      5
          No. of Deals




                         8                                                                                5
                                                                                                                                      4          4
                                                                                           No. of Deals




                         6
                                                                                                          4
                         4               3
                                                  1         1        1                                    3
                         2                                                                                                                                      2
                         0                                                                                2
                              North    Europe   Asia-     Middle   South                                  1
                              Americ            Pacific    East     and
                                a                          and     Central                                0
                                                          Africa   Americ                                        Immunol Oncology Respirato              Infectiou
                                                                     a                                             ogy               ry                  s Disease


         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




KaloBios Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare -                                                                                  Reference Code: GDPH140541D
Deals and Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                  Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       KaloBios Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ................................................ 4
       KaloBios Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ................................................. 5
       KaloBios Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ............................................ 6
       KaloBios Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 .................................. 7
       KaloBios Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013.............................................. 8
       KaloBios Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deal Details ................................................................................. 10
          Venture Financing......................................................................................................................................................................... 10
             Kalobios Pharma Raises Additional $3 Million In Series E Financing ....................................................................................... 10
             KaloBios Pharma Secures $32 Million In Series D Financing ................................................................................................... 11
             KaloBios Pharma Secures $20 Million In Series C Financing ................................................................................................... 14
          Partnerships.................................................................................................................................................................................. 16
             Sanofi Pasteur Enters Into Co-Development Agreement With KaloBios ................................................................................... 16
          Licensing Agreements .................................................................................................................................................................. 18
             KaloBios Pharma Enters Into Licensing Agreement With BioWa And Lonza ............................................................................ 18
             BioWa Enters Into License Agreement With KaloBios Pharma ................................................................................................. 19
             KaloBios Enters Into Licensing Agreement With Novartis ......................................................................................................... 20
          Equity Offering .............................................................................................................................................................................. 21
             KaloBios Pharma Completes IPO For $70 Million ..................................................................................................................... 21
       KaloBios Pharmaceuticals, Inc. - Key Competitors .......................................................................................................................... 23
       Key Employees ................................................................................................................................................................................ 24
       Locations And Subsidiaries .............................................................................................................................................................. 25
          Head Office ................................................................................................................................................................................... 25
       Recent Developments ...................................................................................................................................................................... 26
          Corpor
								
To top